Gelonghui November 7th, JIMIN Health (603222.SH) announced that in order to cultivate and integrate potentially promising assets, help the company's industrial transformation and upgrading, the company plans to jointly establish an industrial investment fund with Shanghai Guoke Longhui Private Equity Fund Management Co., Ltd. (referred to as "Guoke Longhui Private Equity Fund") to focus on investing in growth-stage technology innovation enterprises - Guoke Jimin Xin Zhi Shengchanlichuang Investment Partnership Enterprise (Limited Partnership) (referred to as "Industrial Fund") (the final name is subject to the approval of the Market Supervision Administration). The total committed capital of the industrial fund is 500 million yuan, with Guoke Longhui Private Equity Fund as the general partner, manager, and executive partner, contributing 0.5 million yuan; Jimin Health is a limited partner, contributing 499.5 million yuan. The fund mainly invests in the direction of new productive forces, focusing on high-quality enterprises in the growth stage, with a focus on investing in technology innovation enterprises, technology transfer projects, etc., and can participate in corporate mergers and acquisitions.